Molecular genetic analysis of cerebral cavernous malformations: an update

Abstract

Cerebral cavernous malformations (CCM) can occur either as sporadic or familial form with autosomal dominant inheritance. Three CCM genes have been identified: CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10). In this review, we provide an overall update on genetics of cerebral cavernous malformations. We discuss the main features of these three genes and provide an updated listing of the mutations identified so far. Most of them lead to a premature stop codon regardless of the nature of the variation, including nonsense mutations, small deletions/insertions, and intronic/exonic substitutions causing an altered splicing and a frame-shift. In addition, deletions or duplications of one or more exons of CCM genes can be responsible for the disease. We examine the use of different mutation screening methods to identify all these mutations, providing a comprehensive approach to CCM genetic diagnosis. We also report the main strategies to evaluate the actual impact of the mutations on the protein function. Moreover, we recapitulate the available data on penetrance, phenotype-genotype correlations, and founder effect. Finally, we discuss the main aspects of genetic counseling, including genetic risk assessment in family members, in sporadic patients with multiple CCMs, and in the case of de novo mutations.

Keywords

KRIT1 / CCM2 / PDCD10 gene variants / de novo mutation / penetrance / phenotype-genotype correlation / genetic counseling / screening methods

References

[1] Riant F,Ayrignac X,Tournier-Lasserve E.Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.FEBS J2010;277:1070-5

[2] Labauge P,Brunereau L,Tournier-lasserve E.Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families.Lancet1998;352:1892-7

[3] Petersen TA,Schrader RM.Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.AJNR Am J Neuroradiol2010;31:377-82 PMCID:PMC4455949

[4] Labauge P,Coubes P.Appearance of new lesions in two nonfamilial cerebral cavernoma patients.Eur Neurol2001;45:83-8

[5] Verlaan DJ,Sure U.CCM1 mutation screen of sporadic cases with cerebral cavernous malformations.Neurology2004;62:1213-5

[6] Rigamonti D,Drayer BP.Cerebral cavernous malformations. Incidence and familial occurrence.N Engl J Med1988;319:343-7

[7] Sirvente J,Wassef M,Labauge P.Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations.J Eur Acad Dermatol Venereol2009;23:1066-72

[8] Labauge P,Denier C,Gaudric A.Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.Arch Ophthalmol2006;124:885-6

[9] Laberge-le Couteulx S,Labauge P.Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.Nat Genet1999;23:189-93

[10] Denier C,Labauge P.Société Française de NeurochirurgieMutations within the MGC4607 gene cause cerebral cavernous malformations.Am J Hum Genet2004;74:326-37 PMCID:PMC1181930

[11] Bergametti F,Labauge P.Société Française de NeurochirurgieMutations within the programmed cell death 10 gene cause cerebral cavernous malformations.Am J Hum Genet2005;76:42-51 PMCID:PMC1196432

[12] Morrison L. Cerebral cavernous malformation, familial. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.

[13] Spiegler S,Paperlein C.Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling.Mol Syndromol2018;9:60-9 PMCID:PMC5836221

[14] Stenson PD,Ball EV.The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting.Hum Genet2020;139:1197-207 PMCID:PMC7497289

[15] Clatterbuck RE,Crain BJ.Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.J Neurol Neurosurg Psychiatry2001;71:188-92 PMCID:PMC1737494

[16] Gunel M,Shin D.KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein.Proc Natl Acad Sci U S A2002;99:10677-82 PMCID:PMC125011

[17] Whitehead KJ,Adams JA,Li DY.Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.Development2004;131:1437-48

[18] Yadla S,Shenkar R,Campbell PG.Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution.Neurosurg Focus2010;29:E4 PMCID:PMC6599630

[19] McDonald DA,Shenkar R.Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.Hum Mol Genet2014;23:4357-70 PMCID:PMC4103679

[20] Seker A,Guclu B,Louvi A.CCM2 expression parallels that of CCM1.Stroke2006;37:518-23

[21] Stockton RA,Awad IA.Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.J Exp Med2010;207:881-96 PMCID:PMC2856024

[22] Glading A,Stockton RA.KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions.J Cell Biol2007;179:247-54 PMCID:PMC2064761

[23] Pagenstecher A,Sure U.A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.Hum Mol Genet2009;18:911-8 PMCID:PMC2640205

[24] Haasdijk RA,Maat-Kievit AJ.Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management.Eur J Hum Genet2012;20:134-40 PMCID:PMC3260921

[25] Marchuk DA,Squire TL.Vascular morphogenesis: tales of two syndromes.Hum Mol Genet2003;12 Spec No 1:R97-112

[26] Faurobert E.Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.FEBS J2010;277:1084-96 PMCID:PMC3076058

[27] Zawistowski JS,Lee MF,Marchuk DA.KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis.Hum Mol Genet2002;11:389-96

[28] Scimone C,Marino S,D'Angelo R.Vis-à-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis.Neurol Sci2019;40:243-51

[29] Czubayko M,Schlüter T,Bohnensack R.Sorting nexin 17, a non-self-assembling and a PtdIns(3)P high class affinity protein, interacts with the cerebral cavernous malformation related protein KRIT1.Biochem Biophys Res Commun2006;345:1264-72

[30] Guazzi P,Ferro E.Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1.PLoS One2012;7:e44705 PMCID:PMC3435375

[31] Sedgwick SG.The ankyrin repeat: a diversity of interactions on a common structural framework.Trends Biochem Sci1999;24:311-6

[32] Béraud-Dufour S,Albiges-Rizo C,Faurobert E.Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1.FEBS J2007;274:5518-32 PMCID:PMC2580780

[33] Cavalcanti DD,Martirosyan NL,Spetzler RF.Cerebral cavernous malformations: from genes to proteins to disease.J Neurosurg2012;116:122-32

[34] Verlaan DJ,Stefan H,Siegel AM.Cerebral cavernous malformations: mutations in Krit1.Neurology2002;58:853-7

[35] Maddaluno L,Cuttano R.EndMT contributes to the onset and progression of cerebral cavernous malformations.Nature2013;498:492-6

[36] Liquori CL,Siegel AM.Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.Am J Hum Genet2003;73:1459-64 PMCID:PMC1180409

[37] Fisher OS,Liu D.Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex.Nat Commun2015;6:7937 PMCID:PMC4526114

[38] Draheim KM,Zhang R.CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.J Cell Biol2015;208:987-1001 PMCID:PMC4384732

[39] Bergametti F,Verny C.Novel CCM2 missense variants abrogating the CCM1-CCM2 interaction cause cerebral cavernous malformations.J Med Genet2020;57:400-4

[40] Zawistowski JS,Uhlik MT.CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.Hum Mol Genet2005;14:2521-31

[41] Fisher OS,Zhang R.Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.J Biol Chem2015;290:2842-53 PMCID:PMC4317034

[42] Liquori CL,Squitieri F.Deletions in CCM2 are a common cause of cerebral cavernous malformations.Am J Hum Genet2007;80:69-75 PMCID:PMC1785317

[43] Hilder TL,Bencharit S.Proteomic identification of the cerebral cavernous malformation signaling complex.J Proteome Res2007;6:4343-55

[44] Li X,Zhang H.Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity.J Biol Chem2010;285:24099-107 PMCID:PMC2911348

[45] He Y,Yu L.Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.Sci Signal2010;3:ra26 PMCID:PMC3052863

[46] Dibble CF,Malone MH.Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.PLoS One2010;5:e11740 PMCID:PMC2909203

[47] You C,Dammann P,Sure U.Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.J Cell Mol Med2013;17:407-18 PMCID:PMC3823022

[48] Wang Y,Zhang Y.cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene.Sci China C Life Sci1999;42:323-9

[49] Guclu B,Pricola KL.Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3.Neurosurgery2005;57:1008-13

[50] Chen L,Yano H,Louvi A.Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3.Stroke2009;40:1474-81 PMCID:PMC2709460

[51] Akers AL,Steinberg GK,Marchuk DA.Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.Hum Mol Genet2009;18:919-30 PMCID:PMC2640209

[52] Gault J,Hu LJ.Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.Neurosurgery2006;59:1278-84; discussion 1284

[53] Denier C,Brunereau L.Sociéte Française de Neurochirgurgie, Sociéte de Neurochirurgie de Langue Française. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.Ann Neurol2004;55:213-20

[54] Denier C,Bergametti F.Société Française de NeurochirurgieGenotype-phenotype correlations in cerebral cavernous malformations patients.Ann Neurol2006;60:550-6

[55] Riant F,Fournier HD.CCM3 Mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas.Mol Syndromol2013;4:165-72 PMCID:PMC3666455

[56] Shenkar R,Rebeiz T.Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.Genet Med2015;17:188-96 PMCID:PMC4329119

[57] Gianfrancesco F,Martino T.Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.Am J Med Genet B Neuropsychiatr Genet2007;144B:691-5

[58] Craig HD,Cepeda O.Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27.Hum Mol Genet1998;7:1851-8

[59] Vos IJ, Vreeburg M, Koek GH, van Steensel MA. Review of familial cerebral cavernous malformations and report of seven additional families.Am J Med Genet A2017;173:338-51

[60] Battistini S,Cerase A.Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.Arch Neurol2007;64:843-8

[61] Scimone C,Katsarou Z,D'Angelo R.Two novel KRIT1 and CCM2 mutations in patients affected by cerebral cavernous malformations: new information on CCM2 penetrance.Front Neurol2018;9:953 PMCID:PMC6246743

[62] Gunel M,Finberg K.A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans.N Engl J Med1996;334:946-51

[63] Sahoo T,Thomas JW.Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).Hum Mol Genet1999;8:2325-33

[64] Stahl S,Voss K.Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.Hum Mutat2008;29:709-17

[65] Liquori CL,Gault J.Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.Neurogenetics2008;9:25-31

[66] Cau M,Melis M.C329X in KRIT1 is a founder mutation among CCM patients in Sardinia.Eur J Med Genet2009;52:344-8

[67] Gallione CJ,Awad IA,Marchuk DA.A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.Genet Med2011;13:662-6 PMCID:PMC3132303

[68] Ortiz L,Bellido ML.Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).J Neurol2007;254:322-6

[69] Mondéjar R,Rubio R.Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.PLoS One2014;9:e86286 PMCID:PMC3900513

[70] Perne A,Lehmann L,Stuber F.Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus.Biotechniques2009;47:1023-8

[71] Yao R,Qing Y,Shen Y.Evaluation of copy number variant detection from panel-based next-generation sequencing data.Mol Genet Genomic Med2019;7:e00513 PMCID:PMC6382442

[72] Verlaan DJ,Rouleau GA.Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.Am J Hum Genet2002;70:1564-7 PMCID:PMC379143

[73] Battistini S.Concern regarding classification of c.703G>A/p.Gly235Arg as a novel missense variant in KRIT1 gene.Hum Mutat2020;41:1069-71

[74] Brunak S,Knudsen S.Prediction of human mRNA donor and acceptor sites from the DNA sequence.J Mol Biol1991;220:49-65

[75] Riant F,Cecillon M.Deep intronic KRIT1 mutation in a family with clinically silent multiple cerebral cavernous malformations.Clin Genet2014;86:585-8

[76] Spiegler S,Hoffjan S.First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing.Neurogenetics2018;19:55-9

[77] Labauge P,Bergametti F.Genetics of cavernous angiomas.Lancet Neurology2007;6:237-44

[78] Spiegler S,Liu J.High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors.Mol Genet Genomic Med2014;2:176-85 PMCID:PMC3960060

[79] Rath M,Schwefel K.High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.Eur J Med Genet2017;60:479-84

[80] Lucas M,Montori M,Zayas MD.Germline mutations in theCCM1 gene, encoding Krit1, cause cerebral cavernous malformations.Ann Neurol2001;49:529-32